Biotech/Pharma Stocks Sector Close- Up; Stem Cell Stocks on the Move- Opexa Therapeutics, Inc.(NasdaqCM: OPXA) Trading up$ 1.80 (381.95%)

POINT ROBERTS, Wash., August 7, 2009 www.BiotechIndustryStocks.com, a global investor website for the biotechnology sector within Investorideas.com, presents a biotech stocks sector close- up on stem cell stocks following sharp gains from Opexa Therapeutics, Inc.(NasdaqCM: OPXA). Opexa Therapeutics was up, trading at $ 2.27, up$ 1.80 (381.95%) 11:09AM ET, on news that it entered into an exclusive agreement with Novartis.

Stem Cell Stocks Sector Close –Up Trading August 7 2009
Aastrom Biosciences, Inc.(NasdaqCM: ASTM) trading up at $0.44, up 0.02 (4.76%) 11:05am ET
Geron Corporation(NasdaqGM: GERN) trading at $7.71, up 0.18 (2.39%) 11:06am ET
THERMOGENESIS Corp.(NasdaqCM: KOOL) trading at $0.65,up 0.02 (3.17%) 11:04am ET, trading as high as .72
NEURALSTEM INC(AMEX: CUR) trading at $1.2, up $ 0.10 (8.70%) 10:58am ET
Opexa Therapeutics, Inc.(NasdaqCM: OPXA) trading at $ 2.27, up$ 1.80 (381.95%) 11:09AM ET
StemCells, Inc.(NasdaqGM: STEM) trading at $1.68, up $ 0.05 (3.07%) 11:00am ET


Stem Cell Stock News - Opexa (NASDAQ:OPXA) Announces Stem Cell Agreement with Leading Global Pharmaceutical Company
THE WOODLANDS, Texas- August 7 2009 -Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing a novel T-cell immunotherapy for multiple sclerosis (MS), today announced that it has entered into an exclusive agreement with Novartis, one of the world’s largest pharmaceutical companies, for the further development of Opexa’s novel stem cell technology. This technology, which has generated preliminary data showing the potential to generate monocyte derived islet cells from peripheral blood mononuclear cells, was in early preclinical development at Opexa. Full story


Stem Cell Stock News - ThermoGenesis Announces Launch of Res-Q System; New Device Expands Company's Presence in Bone Marrow Sector

RANCHO CORDOVA, Calif., Aug. 7 2009 -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products for processing and storing adult stem cells, announced today the introduction of the Res-Q(TM) 60 BMC ("Res-Q") System, an automated cell processing medical device for the concentration of bone marrow-derived stem cells at the point of care.

The Res-Q System processes bone marrow in minutes and delivers a high rate of stem cell recovery. The Res-Q System follows the late 2008 launch of the MXP(TM) MarrowXpress(TM) ("MXP") System, a laboratory device also used to collect stem cells from bone marrow.
Full Story

Research More Stem Cell Stocks :
The global Biotech Stocks Directory at Biotechindustrystocks.com and Investorideas.com features a directory of Stem Cell Stocks, Medical Stocks, Life Sciences and Pharma Stocks for investors to research.

Visit the Biotech/Pharma Stock Directory

Biotech public and private companies submit news releases and press releases

About Biotechindustrystocks.com:
BiotechIndustryStocks.com is a global meeting place for investors and industry following the biotech sector, within Investorideas.com. Global visitors use the site daily to research the latest biotech stock and industry news, articles, audio, research reports and our stock directories.
Ask us about becoming a biotech stock showcase company

About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing covering over thirty industry sectors and global markets including China, India, the Middle East and Australia.

Investorideas.com Membership – Access full Biotech Stocks Directory, water stocks and more… Research stem cell stocks as an Investor Ideas Member
With markets and investor sentiment changing daily- it is more important than ever to stay on top of key trends! Gain Exclusive Insight on Leading Sectors, Global Trends, and Insider Trading Ideas, News, Articles and Investor Ideas Members only Restricted Content including the complete renewable energy stocks directory, water stocks, biotech and defense stocks directory, as well as the Insiders Corner by Michael Brush.
Become an InvestorIdeas.com Member

InvestorIdeas.com Disclaimer: www.InvestorIdeas.com/About/Disclaimer.asp
Our sites do not make recommendations, but offer information portals to investors to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of any information presented. All information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is compensated by featured companies, news submissions and online advertising. Disclosure- Investorideas.com was long KOOL at time of release .

For more information contact:
Dawn Van Zant 800.665.0411 dvanzant@investorideas.com
Or cvanzant@investorideas.com